This protocol addresses Sheehan syndrome presenting in premenopausal females with central hypogonadism characterised by low serum estrogens and oligomenorrhea or amenorrhea.
In premenopausal females, Sheehan syndrome manifests with low serum estrogens and impaired ovulation, resulting in oligomenorrhea or amenorrhea. These features define the central hypogonadism component that requires targeted management.
Gonadal hormone replacement is recommended for premenopausal women with central hypogonadism when no contraindications are present. The appropriate preparation varies according to the patient's clinical situation.
DOI: 10.1210/jc.2016-2118
In premenopausal females, it manifests with low serum estrogens and impaired ovulation with oligomenorrhea or amenorrhea.
We recommend gonadal hormone treatment in premenopausal women with central hypogonadism, provided there are no contraindications.
For premenopausal women with central hypogonadism, clinicians should prescribe gonadal hormone replacement (unopposed estrogens for women who have undergone hysterectomy, or combined estrogen-progestogen preparations for those with an intact uterus to prevent endometrial hyperplasia).
View source ↗